Cover Image
市場調查報告書

神經調節技術的策略性展望

Neuromodulation Technologies - A Strategic Perspective

出版商 Technical Insights (Frost & Sullivan) 商品編碼 353929
出版日期 內容資訊 英文 62 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
神經調節技術的策略性展望 Neuromodulation Technologies - A Strategic Perspective
出版日期: 2016年02月24日 內容資訊: 英文 62 Pages
簡介

本報告提供神經調節的技術及市場調查,技術概要,已上市產品分析,價值鏈,市場成長及技術引進的推進因素與課題,投資與策略,策略性聯盟分析,OEM的成長策略,從OEM的「value-to-cost」經營模式轉移到「value-to-serve」經營模式相關檢驗等彙整資料。

第1章 摘要整理

第2章 技術趨勢、分析

  • 神經調節技術概要
  • 市售產品概要
  • 技術趨勢的評估
  • 技術價值鏈分析
  • 神經調節設備的基準
  • 層級分析法 (AHP)
  • 用途發展藍圖
  • 主要調查結果

第3章 產業趨勢、分析

  • 全球神經調節產業概要
  • 市場推動成長因素及課題的影響
  • 技術引進的促進要素及課題的影響
  • 產業的投資、策略分析
  • 策略性聯盟分析
  • OEM相關利益者的策略性分析

第4章 策略評估

  • 策略性差距分析
  • OEM的主要成長策略
  • 「Value for Cost」經營模式

第5章 分析師的考察

  • OEM的「Value-to-Serve」經營模式
  • 分析師分析

第6章 主要專利清單

  • 取得OEM的專利的配合措施
  • 主要專利
  • 主要的進入經營者的清單
  • 免責聲明

第7章 附錄

第8章 關於Frost&Sullivan

目錄
Product Code: D6D1-01-00-00-00

Evaluating Technology's Role in Driving Strategic Transformation within Global Neuromodulation Industry

Over the past decade, global industry leaders offering neuromodulation technologies have been largely successful in implementing large scale value stream transformation programs in setting a mature cost-to-serve model. However, understanding the gaps between OEM initiatives in delivering value to care payers and payer demands have been limited. This research service offers a strategic perspective on the industry, analyzing the gaps between technology push-pull factors that are poised to enable OEMs sustain both volume growth and margin. This research also examines how OEMs can shift from a value-to-cost model to a value-to-serve business model, which plays a lead role in delivering personalized value to healthcare payers and care providers.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1. Scope of Research
  • 2. Research Methodology
  • 3. Key Findings
  • 4. Key Findings
  • 5. Key Findings
  • 6. Key Findings

2. TECHNOLOGY TRENDS & ANALYSIS

  • 1. Snapshot of Neuromodulation Technologies
  • 2. Snapshot of Neuromodulation Technologies
  • 3. Snapshot of Commercial Products
  • 4. Snapshot of Commercial Products
  • 5. Evaluation of Technology Trends
  • 6. Analysis of Technology Value Chain
  • 7. Analysis of Technology Value Chain
  • 8. Benchmarking of Neuromodulation Devices
  • 9. Analytical Hierarchical Process (AHP)
  • 10. Analytical Hierarchical Process (AHP)
  • 11. Application Roadmap
  • 12. Application Roadmap
  • 13. Application Roadmap
  • 14. Key Findings

3. INDUSTRY TRENDS & ANALYSIS

  • 1. Snapshot of Global Neuromodulation Industry
  • 2. Impact of Market Drivers and Challenges
  • 3. Impact of Technology Drivers and Challenges
  • 4. Analysis of Industry Investments and Strategy
  • 5. Analysis of Industry Investments and Strategy
  • 6. Analysis of Strategic Partnerships
  • 7. Analysis of Strategic Partnerships
  • 8. Analysis of Strategic Partnerships
  • 9. Strategic Analysis of OEM Stakeholders
  • 10. Strategic Analysis of OEM Stakeholders

4. STRATEGY ASSESSMENT

  • 1. Analysis of Strategic Gaps
  • 2. Key Growth Strategies of OEMs
  • 3. Value-for-Cost Business Model

5. ANALYST INSIGHTS

  • 1. Value-to-Serve Business Model for OEMs
  • 2. Analyst Insights

6. LIST OF KEY PATENTS

  • 1. Key IP Creation Activities of OEMs
  • 2. Key Patents (1/3)
  • 3. Key Patents (2/3)
  • 4. Key Patents (3/3)
  • 5. List of Key Industry Participants
  • 6. Legal Disclaimer

7. APPENDIX

  • 1. Analytical Hierarchical Process
  • 2. Explanation of Benchmarking Criteria
  • 3. Liberatore's Rating Scale

8. THE FROST & SULLIVAN STORY

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition: Future of Your Company & Career
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top